Home | About PharmaCorner | Guest Book | Advertising | Site Map | Contact us
22 May 2013 Welcome visitor
Search
Login | Register
Pharmacy Ethics
The Calculator
Pharmacy News
Ask The Expert
FAQ´s
Training Programs
Parenteral Medications
Hazardous Medications
Continuing Education
Pharmacy History
Public Education
Important Links


 
Enter your Email address

Home > Pharmacy News > Drug Approvals

FDA advisory committee meeting: Truvada for Pre-Exposure Prophylaxis (PrEP)
Approval of Paradaxa for Stroke Prevention
Botox Injection for Chronic Migraine
Vivitrol Approval for Opioid-Dependent Patients
Breast-Feeding for 6 Months May Prevent Infant Infections
Beyaz: A Combination Contraceptive and Folate
First Oral Drug to Reduce MS Relapses
FDA Approves Lumigan 0.01% Ophthalmic Solution
Schizophrenia Drug Approved for 2 New Uses
FDA Proposes Withdrawal of Low Blood Pressure Drug
US FDA Approves Xeomin
FDA Approves Cuvposa for Chronic Drooling in Children
FDA Approves a New Hypertension Polypill
US FDA Approves Doxepin for Treatment of Insomnia
A new Promising Weight Loss Drug
A New Immunotherapy for Prostate Cancer
A New Rapid Test for Hepatitis C Virus Antibodies
Generic Effexor Extended Release Capsules For Major Depressive Disorder
US FDA approves Jalyn for Benign Prostatic Hypertrophy
OVA1 Test for Ovarian Cancer
New Generic of Starlix
Expanded Indication for Zevalin
Approval of Hiberix Vaccine
Avastin Approved for Renal Cell Carcinoma
Saphris Approval For Schizophrenia and Bipolar Disorder
FDA Approves Sumavel DosePro
WHO Approves Cervical Cancer Vaccine Cervarix
FDA approves Multaq for Atrial Fibrillation and Flutter
Caldolor(TM): An Intravenous Ibuprofen Approved
Ozurdex Approved for Macular Edema Following Retinal Vein Occlusion
First Batch of Swine Flu Vaccine
Besivance Approved for Pink Eye Treatment
FDA Approves Synvisc-One for Knee Osteoarthritis
Expanded FDA approval for Copaxone
RiaSTAP Approved for Congenital Fibrinogen Deficiency
AllerNaze™ Approved for Allergic Rhinitis
Epiduo: A new Combination Acne Gel
Degarelix Approved for Patients with Advanced Prostate Cancer
MPX Test : A First Nucleic Acid Test to Screen for HIV in Donated Blood and Tissue
SELZENTRY™ Approved For Treatment-Experienced HIV Patients
Recommendations to Approve Febuxostat for Patients With Gout
Tapentadol a New Pain Killer
Newly Manufactured Sucraid Will Prevent its’ Shortage
Approval of Generic Version of the Antidepressant Effexor XR(R)
New Indication for Premarin Vaginal Cream
Apidra(R) Approved for Children With Diabetes Mellitus
Ranexa(R) Approved for the Treatment of Chronic Angina
Approval of Generic Version of UCB Pharma's Keppra(R)
New Indication for Norditropin(R)
A New Drug to Treat Overactive Bladder
USA 2008-2009 Seasonal Influenza Vaccines Approved
Approval of Cardene® Premixed Injection
Approval of First Generic Versions of Divalproex Sodium
A New Warfarin Sensitivity Test
EOVIST(R) Approved to Detect Focal Liver Lesions
A New Genetic Test for Breast Cancer
First Generic Versions of Risperdal Approved
Nexium expanded for Use in younger Children
Xyntha: A new Antihemophilic Factor Approved
MIRCERA: A first Monthly Treatment of Anemia for CRF Patients
Zyrtec-D approved as nonprescription drug for allergies
Approval of Combigan Eye Drops for Glaucoma
Voltaren Gel for Osteoarthritis
FDA Approves Antibiotic Ointment for Children and Adults
Ixempra approved for metastatic or locally advanced breast cancer
Menactra use is expanded for younger children
Doripenem approved for treatment of complicated infections
Raltegravir: A new treatment approved for HIV infection
First Generic Versions of Trileptal Approved
New generic Clarithromycin suspension approved.
Lamisil granules approved for pediatric fungal infections
Totect approved for Anthracycline extravasations’ treatment in USA
A New Indication for Evista approved by FDA
FDA Approves Second-Generation Smallpox Vaccine
FDA Approves New Drug to Treat Acromegaly
FDA Approves Human Thrombin for Topical Use in Surgery
Approval of Aliskiren For Hypertension in Europe
 

 

All Rights Reserved to pharmacorner 2007 - Disclaimer - Contact us